{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T20:18:02Z","timestamp":1772569082517,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,27]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>The prevalence of idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is &lt;1\/1,000,000, and it tends to occur in young women. Panretinal photocoagulation, focal laser photocoagulation, peripheral cryopexy, vitrectomy, and corticosteroid therapy are the traditional treatments. We reported a case of a senile patient with IRVAN syndrome who presented with severe exudation in both eyes and macular edema in the left eye, successfully treated by serial intravitreal aflibercept injections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient Concerns:<\/jats:title>\n            <jats:p>A 77-year-old Taiwanese woman complained of progressive blurred vision in the left eye and ocular examinations revealed a visual acuity of 20\/125 in the left eye.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Indirect fundoscopy and fluorescein angiography showed bilateral multiple aneurysms, vasculitis, optic nerve staining, and neovascularizations. In addition, optical coherence tomography demonstrated macular edema with subretinal fluid and exudations in the left eye.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Monthly intravitreal injections of antivascular endothelial growth factor with aflibercept 2.0\u2009mg were administered in the left eye.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The visual acuity in the left eye improved to 20\/50 after 18 months of treatment. Macular edema and subretinal fluid regressed. Furthermore, vessel leakage and optic disc staining also improved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case is the first to demonstrate successful treatment of IRVAN syndrome-related central macular edema and exudations, in the absence of neovascularization, using a series of intravitreal aflibercept injections as monotherapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000039768","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T21:02:07Z","timestamp":1727470927000},"page":"e39768","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Successful treatments of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome\u2013related macular edema and exudation by intravitreal aflibercept injection in a senile patient: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2800-0323","authenticated-orcid":false,"given":"Hsiao-Fan","family":"Tung","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, China Medical University Hospital, China Medical University, Taichung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Sheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Changhua Christian Hospital, Changhua, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-381X","authenticated-orcid":false,"given":"San-Ni","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, China Medical University Hospital, China Medical University, Taichung, Taiwan"},{"name":"Department of Optometry, Da-Yeh University, Changhua, Taiwan"},{"name":"School of Medicine, Chung-Shan Medical University, Taichung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0161-6420(95)30907-4","article-title":"Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis. Retinal Vasculitis Study.","volume":"102","author":"Chang","year":"1995","journal-title":"Ophthalmology"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.ophtha.2006.11.014","article-title":"Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system.","volume":"114","author":"Samuel","year":"2007","journal-title":"Ophthalmology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/j.1755-3768.2009.01540.x","article-title":"Intravitreal bevacizumab (Avastin) in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis.","volume":"88","author":"Akesbi","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/112067211002000425","article-title":"Ranibizumab for idiopathic retinal vasculitis, aneurysms, and neuroretinitis: favorable results.","volume":"20","author":"Karagiannis","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/ICB.0000000000001020","article-title":"Efficacy of intravitreal aflibercept injections in the treatment of idiopathic retinal vasculitis, aneurysms and neuroretinitis syndrome.","volume":"16","author":"Jones","year":"2022","journal-title":"Retin Cases Brief Rep"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3928\/23258160-20131105-09","article-title":"Combination anti-VEGF and corticosteroid therapy for idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome.","volume":"44","author":"Sawhney","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcjo.2017.12.015","article-title":"Long-term outcomes in a series of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome.","volume":"53","author":"Massicotte","year":"2018","journal-title":"Can J Ophthalmol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41433-018-0021-7","article-title":"Clinical pharmacology of intravitreal anti-VEGF drugs.","volume":"32","author":"Fogli","year":"2018","journal-title":"Eye (Lond)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:48:11Z","timestamp":1746319691000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":8,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039768","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}